Speed Innovation Happiness. Corporate Overview
|
|
- Juniper Walton
- 6 years ago
- Views:
Transcription
1 Corporate Overview
2 Contents Bilcare Overview Businesses Business Strategy Financial Overview 2
3 Bilcare Overview 3
4 Bilcare Overview Our Objective Vision Delivering Innovation Transforming Lives Values Speed Innovation Happiness Proactive and swift action is our mantra Our constant approach at all levels is to seek better ways of listening, thinking and doing - making our offerings meaningful and impactful We are motivated by our customer's success and happiness of our stakeholders. 4
5 Bilcare Overview Business Overview Market position Revenues Customers Global Footprint People Leading provider of Research based Innovative packaging solutions USD 600 million in revenues Over 2500 customers globally Plants in 9 locations across Europe, US and Asia Team of strong professionals globally 5
6
7
8 Businesses 8
9 Businesses Business Verticals Bilcare Solutions Global Clinical Supplies nonclonableid TM Technologies Pharma Packaging Innovations Packaging Films Solutions Accelerating drug development process Solutions for Clinical Trial Programs; facilitating speed to market Anytime, Anywhere Authentication and Trackand-Trace technology for people and products Cards Solutions Specialty Films Solutions 9
10 Businesses Bilcare Solutions Pharma Packaging Innovations Pioneers in providing a wide range of pharmaceutical films & foils, to suit the sensitivity of the drug and strengthen its brand equity Packaging Films Solutions Leading suppliers of wide range of rigid Mono films for Food & FMCG industry Cards Solutions High quality cores and overlays for all kind of cards for Banking, Mobile, Loyalty, Club Memberships, Casinos etc. Specialty Films Solutions High quality Films for sectors such as Printing/ Decoration, Shrink films, Visual packaging, Technical applications and Office materials 10
11 Businesses Global Clinical Supplies End-to-end clinical supplies management services; facilitating speed to market Bilcare GCS provides: Protocol design Regulatory compliance & patient safety Batch manufacturing Packaging design Clinical packaging and randomization Storage and global distribution Returns management Distinctive services to customers in the area of product formulation and development Opportunity to more rapidly and effectively conduct clinical trials, thereby enhancing the speed to market of pharmaceutical products 11
12 Businesses nonclonableid TM Technologies Anytime, Anywhere Authentication and Track-and- Trace technology for people and products. Wide range of Applications Security & ID Cards Document Security Currency Security Pharmaceutical Medical Compliance Agrochemicals High-value components Fashion & Luxury goods nonclonableid TM Benefits Better visibility throughout the supply chain Reliable brand and asset protection Real-time authentication Efficient Inventory management Prevents product diversion and entry of fake products in the supply chain 12
13 Businesses nonclonableid TM Technologies Authentication and Track n Trace Anytime, Anywhere How is it made? How does it work? 13
14 Business Strategy 14
15 Business Strategy Addressing Challenges Compliance Counterfeit Communication Bilcare Packaging Solutions Convenience Cost Global Clinical Supplies Regulatory hurdles R&D and Innovation pipeline deficit Lack of patient population for enrollment Brand Protection Lack of Authentication tools nonclonableid TM Technologies Revenue & Profit leakages Security threats 15
16 Financial Overview 16
17
18
19 Thank you! visit us at 19
Speed Innovation Happiness. Corporate Presentation
Corporate Presentation February 2013 Overview Vision Delivering Innovation - Transforming lives Speed Values Innovation Happiness Proactive and swift action is our mantra Our constant approach at all levels
More informationPresentation. March 2007
Presentation March 2007 1 Corporate Overview 2 Corporate Overview Leading provider of research-driven packaging solutions solely-focused on pharmaceutical industry Founded in 1994 and based in Pune, India
More informationAuthentication Solution for Currency Management
Bilcare Technologies is a division of Bilcare Ltd. focused on creating next-generation anti-counterfeiting, security, and brand protection solutions for a broad range of industry sectors. With breakthrough
More informationIndsec Securities & Finance Ltd.
Stock Details BSE Code : 526853 NSE Code : NA Market Cap (Rs.mn) : 15746.86 Sector Year End : Packaging : March 52 w. High/ Low : 712.80/352.00 Listed On Shs. In Issue (Mn.) : BSE : 22.69 Mn. BSE Sensex
More informationMaking lives better every day. This is UCB
Making lives better every day. This is UCB Kristof, living with axial spondyloarthritis Remi, UCB Inspired by patients. Driven by science. We have a shared ambition to transform the lives of people living
More informationinnovation. delivered.
our films deliver. innovation. delivered. For more than 40 years, Klöckner Pentaplast has been producing the world s most innovative rigid films for the world s most innovative companies. Our films safely
More informationLeader in Pharmaceutical Films
TSX-V: IGX OTCQX: IGXT Leader in Pharmaceutical Films Your Specialist in Contract Development & Manufacturing WE MAKE APPROVED DRUGS BETTER Our Mission We make approved drugs better, with next generation
More informationApril, 2014 GameAccount Network
April, 2014 Disclaimer Certain statements included in this Presentation contain forward-looking information concerning GameAccount Network's strategy, operations, financial performance or condition, outlook,
More informationpeace of mind For from development to commercial supply
For peace of mind from development to commercial supply aesica-pharma.com weshouldtalk@aesica-pharma.com @aesica CorporateBroEng_v2 0814 @ Aesica 2014 Your full service CDMO Our vision: To be the number
More informationIndustry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization
Accenture Life Sciences Rethink Reshape Restructure for better patient outcomes Industry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization Accenture Research Note: Key findings
More informationTapan Ray Director General Organisation of Pharmaceutical Producers of India ALCAN PACKAGING UNIVERSITY OCT 8, LONAVALA
COMBATING COUNTERFEIT DRUGS WITH PACKAGING TECHNOLOGY Tapan Ray Director General Organisation of Pharmaceutical Producers of India ALCAN PACKAGING UNIVERSITY OCT 8, 2009 -LONAVALA Content Counterfeit Medicines:
More informationCOM C. Rozwell
C. Rozwell Research Note 6 October 2003 Commentary Technologies That Ease Pharmaceutical Industry Disruption Several disruptive forces are altering the life science business model. Enterprises must select
More information2008 Course Programs Schedule
2008 Course Programs Schedule Basic Laboratory Safety Laboratory Safety Biostatistics for the Non-Statistician - Basic Applied cgmps for Pharmaceutical and Allied Industries Good Clinical Practices (GCP)
More informationCollegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile The Business
More informationInternational Conference on Pharmaceutical Research and Development June 06-07, 2018 Philadelphia, USA
International Conference on Pharmaceutical Research and Development,, https://research.pharmaceuticalconferences.com Invitation Dear Attendees, We are glad to announce the International Conference on Pharmaceutical
More informationAqua Pharmaceuticals, LLC
Aqua Pharmaceuticals, LLC Corporate Presentation June 2011 AQUA PHARMACEUTICALS, LLC 1 Company Overview Specialty dermatology pharmaceutical company currently focusing on acquiring, developing and marketing
More informationSingular ID. The Story of Commercialising a Materials Technology in Singapore. Adrian Burden
2010 Bilcare Technologies. Privileged presentation, slide 1 Singular ID The Story of Commercialising a Materials Technology in Singapore Adrian Burden Co-founding Director of Singular ID President Europe
More informationUSTGlobal. How Integrated Data and Technology Affect the Healthcare Ecosystem. UST Global Healthcare Contributed Article
USTGlobal How Integrated Data and Technology Affect the Healthcare Ecosystem UST Global Healthcare Contributed Article UST Global Inc, April 2018 Table of Contents Pharmaceuticals and life sciences Wellness
More informationSiegfried at a Glance. March 2018
Siegfried at a Glance March 2018 Who are we? Company founded 140 years ago Long-term tradition of pharmaceutics and chemicals Unique selling proposition (USP): development and manufacturing services of
More informationImplementing Quality Systems
Implementing Quality Systems CGMP By The Sea August 29, 2006 Chris Joneckis, Ph.D. Senior Advisor For CMC Issues Center For Biologics Evaluation And Research Add FDA Bar and Presentation Overview Driving
More informationTHE LONG VIEW IN BRIEF
THE LONG VIEW IN BRIEF April 2016 WORLD LEADER IN GASES, TECHNOLOGIES AND SERVICES FOR INDUSTRY AND HEALTH, AIR LIQUIDE IS PRESENT IN 80 COUNTRIES WITH MORE THAN 50,000 EMPLOYEES AND SERVES MORE THAN 2
More informationInformation & Communication Technology Strategy
Information & Communication Technology Strategy 2012-18 Information & Communication Technology (ICT) 2 Our Vision To provide a contemporary and integrated technological environment, which sustains and
More informationIndustrial Innovation Information Days Brussels 3-4 October 2017
Industrial Innovation Information Days Brussels 3-4 October 2017 NMBP Programme Parallel Sessions OPEN INNOVATION TEST BEDS Calls 2018/2019 Helene CHRAYE, HoU Unit D3 DG Research & Innovation A joint presentation
More informationStarpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio
More information[Overview of the Consolidated Financial Results]
0 1 [Overview of the Consolidated Financial Results] 1. Consolidated revenue totaled 5,108.3 billion yen, increased by 581.1 billion yen (+12.8%) from the previous year. 2. Consolidated operating profit
More informationHealth & Social Care Industrial Innovation
Health & Social Care Industrial Innovation Mr Andrew Fowlie Scottish Government Health Innovations Team SHINE North Sea Region Program 2014 2020 Scotland s Medical Technologies Landscape Imaging Non Imaging
More informationROLE OF INTELLECTUAL PROPERTY RIGHTS IN DEVELOPING COUNTRIES -ASHWINI SANDU.
ROLE OF INTELLECTUAL PROPERTY RIGHTS IN DEVELOPING COUNTRIES -ASHWINI SANDU. Can you guess? How does one protect their brand? Most brands are distinct and being distinctive is the way potential users
More informationDigital Health Startups A FirstWord ExpertViews Dossier Report
AM PL E PA G ES S A G ES S A FirstWord ExpertViews Dossier Report Published Copyright 2016 Doctor s Guide Publishing Limited All rights reserved. No part of this publication may be reproduced or used in
More informationPan-Canadian Trust Framework Overview
Pan-Canadian Trust Framework Overview A collaborative approach to developing a Pan- Canadian Trust Framework Authors: DIACC Trust Framework Expert Committee August 2016 Abstract: The purpose of this document
More informationStakeholder engagement
Stakeholder engagement Dr Malcolm Parry OBE, Managing Director and CEO The Surrey Research Park, University of Surrey Stakeholders objectives - host University / other hosts Some independent income Raise
More informationAnnual Press Conference Financial year 2017
Annual Press Conference 2018 Financial year 2017 Financial year Hubertus von Baumbach Chairman of the Board of Managing Directors 2017 Highly successful financial year 2017 Major success with human pharmaceuticals
More informationQ8 and Q8 annex An industry Perspective
Workshop on Implementation of ICH Q8/Q9/Q10 and Other Quality Guidelines Beijing December 2008 Q8 and Q8 annex An industry Perspective Brian Withers, Abbott Laboratories, United Kingdom I attend this conference
More informationFortis to acquire strategic stake in Parkway Holdings, Singapore
PRESS RELEASE Fortis to acquire strategic stake in Parkway Holdings, Singapore Landmark cross border deal in Healthcare sector out of India Move will establish Fortis as Asia s largest hospital network
More informationCeQur establishes Wales subsidiary
FOR IMMEDIATE RELEASE CeQur establishes Wales subsidiary -- Arthurian Life Sciences investment helps bring to market world s first three-day simple insulin infusion device for type 2 diabetes -- LUCERNE,
More informationTranslational scientist competency profile
C-COMEND Competency profile for Translational Scientists C-COMEND is a two-year European training project supported by the Erasmus plus programme, which started on November 1st 2015. The overall objective
More informationComprehensive Research Services
Comprehensive Research Services Scripps Health: At the Forefront of Clinical Research Scripps Health is a recognized leader in clinical research and has long been at the forefront of numerous medical breakthroughs.
More informationNew Directions for Wearables
An M2M Zone Webinar Where IoT Connects Moderated by: Andy Castonguay Principal Analyst, Machina Research Presenter: Kerwin Myers Sr. Director, Product Management, Numerex May 7, 2015 Sponsored by: Machina
More informationITI Comment Submission to USTR Negotiating Objectives for a U.S.-Japan Trade Agreement
ITI Comment Submission to USTR-2018-0034 Negotiating Objectives for a U.S.-Japan Trade Agreement DECEMBER 3, 2018 Introduction The Information Technology Industry Council (ITI) welcomes the opportunity
More informationReduce cost sharing and fees Include other services. Services: which services are covered? Population: who is covered?
3.3 Assessment: National health technology assessment unit 3.3.1 Introduction Health systems throughout the world are struggling with the challenge of how to manage health care delivery in resource-constrained
More information'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint
'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint STOA workshop - European Parliament, 10 January 2019 Presented
More informationNational Medical Device Evaluation System: CDRH s Vision, Challenges, and Needs
National Medical Device Evaluation System: CDRH s Vision, Challenges, and Needs Jeff Shuren Director, CDRH Food and Drug Administration Center for Devices and Radiological Health 1 We face a critical public
More informationOMCL Network of the Council of Europe GENERAL DOCUMENT
OMCL Network of the Council of Europe GENERAL DOCUMENT PA/PH/OMCL (09) 87 4R OMCL Network support for the implementation of the CoE MEDICRIME Convention Full document title and reference How the OMCL Network
More informationNHS Next Stage Review: Innovation
NHS Next Stage Review: Innovation January 2008 Introduction 1. The Academy of Medical Sciences welcomes the opportunity to contribute to the NHS Next Stage Review. In this short response we have focused
More informationB) Issues to be Prioritised within the Proposed Global Strategy and Plan of Action:
INTERGOVERNMENTAL WORKING GROUP ON PUBLIC HEALTH, INNOVATION AND INTELLECTUAL PROPERTY EGA Submission to Section 1 Draft Global Strategy and Plan of Action The European Generic Medicines Association is
More informationMedical Education Activities
Medical Education Activities Author: Marie-Claire PICKAERT EFPIA Deputy Director General BioMed Alliance Brussels, 9 November 2016 MCP 07-11--2016 Declaration of Interest Marie-Claire Pickaert is a full-time
More informationWIPO-WASME Program on Practical Intellectual Property Rights Issues for Entrepreneurs, Economists, Bankers, Lawyers and Accountants
WIPO-WASME Program on Practical Intellectual Property Rights Issues for Entrepreneurs, Economists, Bankers, Lawyers and Accountants Topic 12 Managing IP in Public-Private Partnerships, Strategic Alliances,
More informationPharma Clean Assurance Programme.
Pharma Clean Assurance Programme www.lcpackaging.com Cleaner, safer and sustainable 02 Innovative FIBC programme for premium pharma clean packaging The biggest challenge for the pharmaceutical industry
More informationTimescales for Change A Look at Innovation in the Pharmaceutical Industry
Timescales for Change A Look at Innovation in the Pharmaceutical Industry 3rd FDA/PQRI Conference on Advancing Product Quality 23 Mar 2017 Robert F. Meyer, Ph.D. Global Pharmaceutical Commercialization
More informationBasque Country. RIS3 EUSKADI & ADVANCED MANUFACTURING STRATEGY Basque Industry 4.0
RIS3 EUSKADI & ADVANCED MANUFACTURING STRATEGY Basque Industry 4.0 MANUMIX INTERREG EUROPE 1 st Learning Journey Basque Country Amaia Martínez Muro Strategic Initiatives. SPRI Basque Business Development
More informationJ.P. Morgan Healthcare Conference Summary Transcript
J.P. Morgan Healthcare Conference Summary Transcript Good afternoon, everyone. I'm Shigeo Taniuchi. I'm President and COO of Santen Pharmaceutical. I joined Santen in 1996, and I became the President and
More informationFDA Centers of Excellence in Regulatory and Information Sciences
FDA Centers of Excellence in Regulatory and Information Sciences February 26, 2010 Dale Nordenberg, MD novasano HEALTH AND SCIEN Discussion Topics Drivers for evolution in regulatory science Trends in
More informationObservations from Pharma
Observations from Pharma Indian Patent Enforcement in the Chemical Arts Gurmeet Kaur Sidhu, Senior Patent Litigation Counsel London, 26/9/11 a Novartis company The Indian Pharmaceutical sector: Overview
More informationThe #1 Partner to Gaming Operators Worldwide
The #1 Partner to Gaming Operators Worldwide NYX OPS Open Platform System Wherever your license, whatever your product, the Open Platform System is for you! Deliver a premium experience to your players
More informationthe Companies and Intellectual Property Commission of South Africa (CIPC)
organized by the Companies and Intellectual Property Commission of South Africa (CIPC) the World Intellectual Property Organization (WIPO) the International Criminal Police Organization (INTERPOL) the
More informationPHARMA S NEW PHASE. Technological integrators play as crucial a role as banks in Big Pharma s latest M&A boom. They re back.
Renew-New PHARMA S NEW PHASE Technological integrators play as crucial a role as banks in Big Pharma s latest M&A boom They re back. Mergers & acquisitions, that is and in a big way. Wall Street and City
More informationWritten Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum
Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum List of recommendations: Recommendation 1: That the government creates a Life Sciences
More informationMara H. Rogers, Partner Norton Rose Fulbright
Mara H. Rogers Partner Norton Rose Fulbright US LLP New York T:+1 212 318 3206 F:+1 212 318 3400 mara.rogers@nortonrosefulbright.com vcard (+Outlook) Related services Corporate, M&A and securities Mergers
More informationCommunication and dissemination strategy
Communication and dissemination strategy 2016-2020 Communication and dissemination strategy 2016 2020 Communication and dissemination strategy 2016-2020 Published by Statistics Denmark September 2016 Photo:
More information(Fig.) JPMA Industry Vision 2025
2. JPMA Industry Vision 2025 Against the background of the changing environment surrounding the pharmaceutical industry and the future predictions *1, we prepared JPMA Industry Vision 2025 Bringing Innovation
More informationCreating a Vision for Health Literacy s Future: The Research Agenda
Creating a Vision for Health Literacy s Future: The Research Agenda The 8th Annual Health Literacy Research Conference Bethesda, Maryland October 14, 2016 1 Today s Agenda Introduction Michael Villaire
More informationKoen Dejonckheere. Professional experience. Board Memberships. Education
Koen Dejonckheere Professional experience KBC SECURITIES GROUP 2002-2008 Managing Director, responsible for Corporate Finance Previously, Koen Dejonckheere was active in Corporate Finance and Private Equity
More informationJapan s FinTech Vision
Japan s FinTech Vision First Comprehensive Industrial Finance Division Economic and Industrial Policy Bureau Ministry of Economy, Trade and Industry 1 FinTech: New Finance to Support the Fourth Industrial
More informationHealth Care and Digital in Italy. Daniela Bianco, Partner e Responsabile Health Care Unit Alessandro Viviani, Principal Expert Digital Strategy
Health Care and Digital in Italy Daniela Bianco, Partner e Responsabile Health Care Unit Alessandro Viviani, Principal Expert Digital Strategy Key drivers and Health Care evolution 1 2 ECONOMIC RESOURCES
More information4. Vision 2: Providing innovative drugs to 8 billion people worldwide
4. Vision 2: Providing innovative drugs to 8 billion people worldwide Strategic points for realizing the vision Responding to diverse needs and issues [Advanced countries] Promoting understanding of the
More informationCambridge Cognition. Neuroscience Digital Health. 30 January 2018
Cambridge Cognition Neuroscience Digital Health 30 January 2018 Disclaimer These presentation materials (the "Presentation Materials") are being solely issued to and directed at persons having professional
More informationParenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy)
Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy) BACKGROUND (Reason or Purpose) The purpose of this Policy is to provide clear principles and guidance about
More informationAnnual Shareholders' Meeting. Stuttgart May 14th 2009
Annual Shareholders' Meeting Stuttgart May 14th 2009 HUGO BOSS in 2008 in EUR mill. Net Sales 1.686 + 6% (fx-adj.) + 3% Gross Profit 1.011 + 7% EBIT before extraordinary items 226 + 9% Cash Flow from operating
More informationMedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)
MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) Table of Contents Executive Summary...3 The need for healthcare reform...4 The medical technology industry
More informationBrazilian industry s activities for international convergence. Walker Lahmann Director of External Trade at ABIFINA Executive Director at Eurofarma
Brazilian industry s activities for international convergence Walker Lahmann Director of External Trade at ABIFINA Executive Director at Eurofarma Mission Congregate companies, institutes and association
More informationVetter. The experts in complex development, aseptic manufacturing and packaging. Facts figures data 2018
Vetter The experts in complex development, aseptic manufacturing and packaging Facts figures data 2018 This is Vetter Founded *50 Sales 2017 Our portfolio Vetter is an international pharmaceutical service
More informationNFC Forum NFC Use Cases
NFC Forum NFC Use Cases Peter Preuss Nokia Chairman NFC Forum Marketing Committee September 2009 THE NFC FORUM 2 History and Membership of the NFC Forum Established in 2004 Founded by Philips, Nokia and
More informationGerresheimer CAPITAL MARKETS DAY 2010
Gerresheimer CAPITAL MARKETS DAY 2010 Gerresheimer Today September 1, 2010 Uwe Röhrhoff, CEO Gerresheimer who we are and what we do Gerresheimer is an important partner of the pharmaceutical and healthcare
More informationProgress in FDA s Drug Product Quality Initiative. Janet Woodcock, M.D. November 13, 2003
Progress in FDA s Drug Product Quality Initiative Janet Woodcock, M.D. November 13, 2003 Impetus for Initiative: Modernization and continuous improvement in pharmaceutical manufacturing sector slow compared
More informationLupin Limited Annual Results FY12. Investor Presentation May being
Lupin Limited Annual Results FY12 Investor Presentation May 2012 Vision: To be an innovation led transnational company Journey over the last decade 5th largest generics player in US Gross Revenues INR
More informationPatenting Strategies. The First Steps. Patenting Strategies / Bernhard Nussbaumer, 12/17/2009 1
Patenting Strategies The First Steps Patenting Strategies / Bernhard Nussbaumer, 12/17/2009 1 Contents 1. The pro-patent era 2. Main drivers 3. The value of patents 4. Patent management 5. The strategic
More informationMachine Vision in Austria
AIT Austrian Institute of Technology Machine Vision in Austria Andreas Vrabl Head of Business Unit High-Performance Image Processing EMVA, Vienna, 16. May 2014 (Draft Version v0.2) Overview Austria AIT
More informationACCOUNTING TREATMENT OF INTELLECTUAL PROPERTY IN THE PHARMACEUTICAL INDUSTRY
Trakia Journal of Sciences, Vol. 9, No 4, pp 63-68, 2011 Copyright 2011 Trakia University Available online at: http://www.uni-sz.bg ISSN 1313-7069 (print) ISSN 1313-3551 (online) Original Contribution
More informationMEDIA RELEASE FOR IMMEDIATE RELEASE 4 JUNE 2014
MEDIA RELEASE FOR IMMEDIATE RELEASE 4 JUNE 2014 A*STAR-HELLMA PARTNERSHIP TO INNOVATE MANUFACTURING PROCESSES Hellma Analytics, a leading company in optics analysis technologies, partners with A*STAR to
More informationSOLUTIONS WITH INSIGHT
SOLUTIONS WITH INSIGHT FROM THE JOENSUU REGION Flexibility, reliability and high quality have made the Joensuu Region a pioneer of medical solutions. Years of experience and continuing development guarantee
More informationCombating Counterfeit Medicines Challenges & Solutions
Combating Counterfeit Medicines Challenges & Solutions XXXIII ALL INDIA STEEL MEDICAL OFFICERS CONFERENCE Presented by M & M Technologies P. Ltd. Meenaxee Padhy A Boon for Manufacturers. A relief for the
More informationInter-Association Task Force
Inter-Association Task Force Presentation to EMA Workshop Prevention of Drug Shortages Based on Quality and Manufacturing Issues 9 th October 2015 1 Topics for Today Background and history of task force
More informationMedical Device Usability Engineering. Product and Service Design Innovation Consultancy
Medical Device Usability Engineering Product and Service Design Innovation Consultancy Delivering Meaningful Innovation PDD services Our integration of multiple disciplines means we offer a comprehensive
More informationEU GMP Evolution or Revolution Scope and drivers for EU GMP changes. August Gordon Farquharson
EU GMP Evolution or Revolution Scope and drivers for EU GMP changes August 2015 Gordon Farquharson EU & PIC/S Harmonisation at IWG level now Slide 2 PharmOut 2015 EU & PIC/S Harmonisation (1) What does
More informationCompliance for Eucomed: The Medical Technology Industry s s Perspective
Compliance for Eucomed: The Medical Technology Industry s s Perspective Rome, May 29, 2009 John Wilkinson Chief Executive - Eucomed Outline Overview of the Medical Technology Industry What is it? How big
More informationWORKING GROUP 3&5: PUBLIC-PRIVATE PARTNERSHIP
WORKING GROUP 3&5: PUBLIC-PRIVATE PARTNERSHIP Susan Tansey / Pirkko Lepola Chair / Co-Chair WG 3&5 1 Role: Facilitate communication between industry and networks Gather examples of good practice from Networks
More informationChiyoda Corporation and Ezra Holdings Limited enter into MOU to establish 50:50 Joint Venture, EMAS CHIYODA Subsea
Chiyoda Corporation and Ezra Holdings Limited enter into MOU to establish 50:50 Joint Venture, EMAS CHIYODA Subsea Chiyoda will invest in Ezra s Subsea Services business, EMAS AMC, to form EMAS CHIYODA
More informationFeature. Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia. 2020, our goal is to become #1 in
Feature Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia Based on our long-term strategic vision toward 2020, our goal is to become #1 in Asia in terms of our
More informationUSTR NEWS UNITED STATES TRADE REPRESENTATIVE. Washington, D.C UNITED STATES MEXICO TRADE FACT SHEET
USTR NEWS UNITED STATES TRADE REPRESENTATIVE www.ustr.gov Washington, D.C. 20508 202-395-3230 FOR IMMEDIATE RELEASE August 27, 2018 Contact: USTR Public & Media Affairs media@ustr.eop.gov UNITED STATES
More informationOE-A Highlights. LOPEC 2017 Main Press Conference. March 29, 2017 ICM, Messe München. Dr. Jeremy Burroughes
Image source: Holst Centre OE-A Highlights LOPEC 2017 Main Press Conference March 29, 2017 ICM, Messe München Dr. Jeremy Burroughes Chair OE-A Board CTO Cambridge Display Technology A working group within
More informationPDA 71 Years of Connecting People, Science and Regulation
PDA 71 Years of Connecting People, Science and Regulation 1 I m happy to be here. Bom Dia. Estou feliz por estar aqui. Richard M. Johnson PDA President & CEO since 2009 38 years experience in US and International
More informationPatenting trends in Indian pharmaceutical industry
Annals of Library and Information Studies Vol. 64, December 2017, pp. 260-267 Patenting trends in Indian pharmaceutical industry Pratibha Gokhale a and Sudha Kannan b a Former Head, Department of Library
More information9 Vaccine SMEs' Needs
9 Vaccine SMEs' Needs As in most innovative sectors, SMEs play a critical role in bridging basic discoveries from academic research to clinical development 36. This could be seen over the last decade with
More informationAutomotive Sector What is our interest in CAV & ITS and Why? Nigel J Francis
Automotive Sector What is our interest in CAV & ITS and Why? Nigel J Francis State of Michigan Automotive Office April 2014 Vision We will leverage the strengths and assets of Michigan s automotive industry
More informationAMCo current. Medpace new in Sebia realised. Spire Healthcare partially realised. Healthcare. Sector insights. Our Healthcare portfolio in 2014
Sector insights The healthcare market is highly complex with global products delivered through local services and channels. The healthcare value chain is intricate, diverse and interdependent. It is a
More informationDigital Financial Solutions to Advance Women s Economic Participation
microlinks.org/events February 4, 2016 Dr. Ruth Goodwin-Groen Better Than Cash Alliance Digital Financial Solutions to Advance Women s Economic Participation Dr. Leora Klapper World Bank Dr. Ruth Goodwin-Groen
More informationDAB+ Digital Radio. Global update. Vasant Venkatramani, WorldDAB IFTV Broadcast Istanbul, November 2018
DAB+ Digital Radio Global update Vasant Venkatramani, WorldDAB IFTV Broadcast Istanbul, 15-16 November 2018 2 1. Radio needs DAB+ 2. DAB+ around the world 3. DAB+ in the car and home 4. About WorldDAB
More informationHow Paediatric Research Networks can help drug development
How Paediatric Research Networks can help drug development Mark Turner An agency of the European Union Why networks? Significant increase in trials and participants Delays are now significant Networks
More informationDammika Peiris, Senior Pharmacovigilance Manager and Head of Chugai Pharma Europe
Key Speakers: Paul Dolin, Head of Pharmacoepidemiology, Takeda Pharmaceuticals Dr. Katrin Freund, Project Excellence Manager (Social Media) Drug Safety & Epidemiology, Novartis Pharma GmbH Dr. Heike Schoepper,
More informationHealth Innovation Manchester
Health Innovation Manchester Accelerating innovation Discover Develop Deploy Our vision is to be a recognised international leader in accelerating innovation that transforms citizens health and wellbeing
More informationUpdate on Progress Implementing the LSIF Anti- Counterfeit Medicines Action Plan
2013/SOM1/LSIF/009 Agenda item: 17 Update on Progress Implementing the LSIF Anti- Counterfeit Medicines Action Plan Purpose: Information Submitted by: United States Life Sciences and Innovative Forum Planning
More information